EMD-50752

Single-particle
2.6 Å
EMD-50752
3D View Gallery
Deposition: 25/06/2024
Map released: 20/11/2024
Last modified: 27/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-50752

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9ftz summary report (pdf.gz) Map-9ftz FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

CIII2/CIV respiratory supercomplex from Mycobacterium smegmatis with lansoprazole sulfide

EMD-50752

Single-particle
2.6 Å
EMD-50752
3D View Gallery
Deposition: 25/06/2024
Map released: 20/11/2024
Last modified: 27/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Mycolicibacterium smegmatis
Sample: The respiratory supercomplex
Fitted models: 9ftz

Deposition Authors: Kovalova T , Krol S, Gamiz-Hernandez A, Sjostrand D, Kaila V, Brzezinski P , Hogbom M
Inhibition mechanism of potential antituberculosis compound lansoprazole sulfide.
Kovalova T , Krol S, Gamiz-Hernandez AP , Sjostrand D, Kaila VRI , Brzezinski P , Hogbom M
(2024) PNAS , 121 , e2412780121 - e2412780121
PUBMED: 39531492
DOI: doi:10.1073/pnas.2412780121
ISSN: 1091-6490
ASTM: PNASA6